|
Variable
|
CardioBBEAT
|
TIM-HF
|
INH
|
|---|
|
Usual care
|
Monitoring
|
Usual care
|
Monitoring
|
Usual care
|
Monitoring
|
|---|
|
(n = 319)
|
(n = 302)
|
(n = 356)
|
(n = 354)
|
(n = 363)
|
(n = 352)
|
|---|
|
Demographic profile
| | | | | | |
|
Age (years)
|
63.5 ± 11.4
|
62.5 ± 11.6
|
66.9 ± 10.5
|
66.9 ± 10.8
|
69.4 ± 11.5
|
67.7 ± 12.8
|
|
Male sex (%)
|
88
|
87
|
82
|
81
|
71
|
71
|
|
Living alone (%)
|
24
|
27
|
22
|
21
|
35
|
30
|
|
Clinical profile
| | | | | | |
|
NYHA class (%)
| | | | | | |
|
I
|
0
|
0
|
0
|
0
|
2
|
3
|
|
II
|
65
|
73
|
51
|
50
|
62
|
54
|
|
III
|
34
|
26
|
49
|
50
|
31
|
40
|
|
IV
|
1
|
1
|
0
|
0
|
5
|
3
|
|
Risk factor profile
| | | | | | |
|
BMI (kg/m2)
|
28 ± 5
|
28 ± 5
|
28 ± 5
|
28 ± 5
|
n.a.
|
n.a.
|
|
Diabetes mellitus (%)
|
32
|
38
|
39
|
40
|
36
|
36
|
|
Hypertension (%)
|
84
|
87
|
66
|
68
|
77
|
72
|
|
Diagnostic
| | | | | | |
|
Heart rate (1/min)
|
72 ± 14
|
72 ± 13
|
71 ± 13
|
71 ± 13
|
80 ± 18
|
80 ± 20
|
|
LVEF (%)
|
31 ± 7
|
30 ± 8
|
27 ± 6
|
27 ± 6
|
30 ± 8
|
30 ± 8
|
|
Medication (%)
| | | | | | |
|
ACE inhibitor/ARB
|
93
|
93
|
97
|
94
|
87
|
89
|
|
Beta blocker
|
95
|
96
|
93
|
92
|
79
|
81
|
|
Diuretics
|
80
|
83
|
94
|
94
|
86
|
90
|
- ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, BMI body mass index, LVEF left ventricular ejection fraction, n.a. not available, NYHA New York Heart Association, classification of heart failure
